Antitumor activity of triptolide in SKOV3 cells and SKOV3/DDP in vivo and in vitro-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Antitumor activity of triptolide in SKOV3 cells and SKOV3/DDP in vivo and in vitro

Published:2020-06 Issue:5 Volume:31 Page:483-491
ISSN:0959-4973
Container-title:Anti-Cancer Drugs
language:en
Short-container-title:

Author:

Hu Hui,Zhu Sihong,Tong Yan,Huang Genhua,Tan Buzhen,Yang Lilan

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Pharmacology (medical),Pharmacology,Oncology

Reference35 articles.

1. Preservation of fertility in patients with cancer (review).;Del-Pozo-Lérida;Oncol Rep,2019

2. Mucinous borderline ovarian tumor versus invasive well-differentiated mucinous ovarian cancer: difference in characteristics and outcomes.;Matsuo;Gynecol Oncol,2019

3. Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: the ICON4/AGO-OVAR-2.2 trial.;Parmar;Lancet,2003

4. International patterns and trends in ovarian cancer incidence, overall and by histologic subtype.;Coburn;Int J Cancer,2017

5. Integrative genome-wide expression and promoter DNA methylation profiling identifies a potential novel panel of ovarian cancer epigenetic biomarkers.;Gloss;Cancer Lett,2012

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sorcin in Cancer Development and Chemotherapeutic Drug Resistance;Cancers;2024-08-09

2. The Emerging Role of Natural Products in Cancer Treatment;Archives of Toxicology;2024-05-25

3. Tasquinimod enhances the sensitivity of ovarian cancer cells to cisplatin by regulating the Nur77-Bcl-2 apoptotic pathway;Advances in Clinical and Experimental Medicine;2023-07-28

4. Anticancer plant-derivatives: deciphering their oncopreventive and therapeutic potential in molecular terms;Future Journal of Pharmaceutical Sciences;2023-02-21

5. lncRNA-CCAT2 Reduces the Drug Resistance of Ovarian Cancer Cells;Journal of Biomaterials and Tissue Engineering;2022-07-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3